Study on the Mechanism of Compound Kidney-Invigorating Granule for Osteoporosis based on Network Pharmacology and Experimental Verification

Figure 12

Identification of hBMSCs. hBMSCs at passage 4 were identified with flow cytometry. (a–d) The cell morphology of passage 1 (day 6), 2 (day 5), 3 (day 5), and 4 (day 4), respectively. Flow cytometry was used to analyze the levels of the biomarkers in hBMSCs (e–g). The hBMSCs were positive for CD29 (e), CD44 (f), and negative for CD34 (g).

(a)

(b)

(c)

(d)

(e)

(f)

(g)